scispace - formally typeset
C

Claire Delacour

Publications -  6
Citations -  203

Claire Delacour is an academic researcher. The author has contributed to research in topics: Soman & Brain damage. The author has an hindex of 5, co-authored 5 publications receiving 192 citations.

Papers
More filters
Journal ArticleDOI

Prolonged inflammatory gene response following soman-induced seizures in mice.

TL;DR: A quick neuro-inflammatory gene response that does not subside over 7 days is indicated suggesting a potential role in the neurological consequences of soman-induced status epilepticus.
Journal ArticleDOI

Cerebral edema induced in mice by a convulsive dose of soman. Evaluation through diffusion-weighted magnetic resonance imaging and histology

TL;DR: The ADC decrease observed in the present study suggests that brain edema in soman poisoning is mainly intracellular and cytotoxic, while anesthesia was shown to interrupt soman-induced seizures and to attenuate edema and cell change in certain sensitive brain areas.
Journal ArticleDOI

An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX

TL;DR: Results suggest that the rebound of plasma ChE activity following inhibition provoked by the intravenous injection of 6 and 12 microg kg(-1) of VX was likely due to the release of butyrylcholinesterase into the blood stream from ChE producing organs.

Soman-Induced Seizures and Related Brain Damage: How to Treat Seizures and Assess Their Effects Non-Invasively?

TL;DR: The present review will address four points: the medical issues raised by the central effects of soman poisoning; the mechanism of Soman-induced brain damage; the use of antagonists of ionotropic glutamate receptors as anticonvulsants and neuroprotectants; and the search for new non-invasive methods to assess the progression of somAn-inducedbrain damage.
Journal ArticleDOI

Distortion product otoacoustic emissions as non-invasive biomarkers and predictors of soman-induced central neurotoxicity: a preliminary study.

TL;DR: In this article, distortion product otoacoustic emissions (DPOAEs) were used to monitor cochlear functionality in rats administered with a moderate dose of organophosphorus nerve agent (45 μg/kg).